ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Does Systematic Medication Review in Elderly Patients Admitted to Orthopedic Departments Reduce Admission Time?

This study is not yet open for participant recruitment.
Verified by University of Aarhus, August 2008

Sponsored by: Aarhus University Hospital
Information provided by: University of Aarhus
ClinicalTrials.gov Identifier: NCT00738816
  Purpose

Elderly patients has a higher risk of experiencing adverse drug events due to an age related increase in morbidity and medication use. Inappropriate or wrong medication use among elderly patients acutely admitted to hospitals is assumed to prolong patients inhospital stay if not corrected at admission to hospital. It is therefore our hypothesis that a systematic medication review conducted by pharmacists and physicians specialized in pharmacology will decrease elderly patients admission time in Orthopedic Departments from an average of five days to four days. Further, the following secondary outcome parameters will be measured at 3 and 12 month follow up:

  • time to first re-admission,
  • number of re-admissions,
  • number of death,
  • number of contact to primary health care
  • patients self-experienced quality of health (EQ-5D)

Condition Intervention
Elderly
Other: Systematic medication review and advisory notes

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety Study
Official Title:   The Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department.

Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Admission time for elderly patients >70 years admitted to an Orthopedic Department [ Time Frame: February 2009 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Time to first re-admission, Nb. of re-admission; death, Nb. of contacts to General practitioner;community nurses;emergency rooms, ambulatories;Finally patients self-experienced quality of life (EQ-5D questionnaire) [ Time Frame: 3 and 12 month after admission date ] [ Designated as safety issue: No ]

Estimated Enrollment:   100
Study Start Date:   September 2008
Estimated Study Completion Date:   October 2009
Estimated Primary Completion Date:   February 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
Intervention
Systematic medication review
Other: Systematic medication review and advisory notes
Within 24 hours of admission a pharmacist retrieve medication histories from patients included in the intervention group. Medication histories will be obtained from - medical records, medication charts, patients electronical medication profile, interview with patients and if necessary contact to the patients general practitioner. The obtained medication history will be discussed with a physician specialized in pharmacology and an advisory note with suggested changes to the patients medication is added to the medical record. The orthopedic physicians are not obliged to follow the suggested changes

  Eligibility
Ages Eligible for Study:   70 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • age > 70 years
  • expected admission time of more than 24 hours
  • acute admission

Exclusion Criteria:

  • Psychotic patients
  • Moribund patients
  • Suicidal patients
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00738816

Contacts
Contact: Marianne Lisby, MHSc     +45 61264949     lisby@as.aaa.dk    

Locations
Denmark, Central Denmark Region
Regional hospital, Randers     Not yet recruiting
      Randers, Central Denmark Region, Denmark, 8900
      Contact: Lars Peter Nielsen, MD     +45 89421987     lpn@dadlnet.dk    
      Principal Investigator: Marianne Lisby, MHSc            

Sponsors and Collaborators
Aarhus University Hospital
  More Information


Publications:

Responsible Party:   Aarhus University Hospital ( Marianne Lisby )
Study ID Numbers:   Klinfarm
First Received:   August 20, 2008
Last Updated:   August 20, 2008
ClinicalTrials.gov Identifier:   NCT00738816
Health Authority:   Denmark: Danish Dataprotection Agency;   Denmark: The Danish National Committee on Biomedical Research Ethics

Keywords provided by University of Aarhus:
Medication review  
Patient  
Safety  
Drug
Prescriptions
Drug-use

ClinicalTrials.gov processed this record on October 15, 2008




Links to all studies - primarily for crawlers